Source: cbc.ca, August 31, 2020
The vaccine, should it work and be safe, would be available to Canadians as early as the second quarter of 2021.
Canada’s federal government has signed agreements with two U.S. drug companies to secure up to 114 million doses of potential COVID-19 vaccines under development.
Maryland-based biotechnology company Novavax announced in a press release Monday that it has struck a deal to produce 76 million doses of a vaccine it is working on for the Canadian government, should the vaccine ever get Health Canada approval.
For the latest information and for more updates on everything Kindersley ‘Like’ the Kindersley Social Facebook page below…